GlobeNewswire Inc.··Holzer & Holzer, LlcEntrada Therapeutics Under Investigation Over DMD Trial Disappointment
Law firm investigates $TRDA over securities compliance following underwhelming Duchenne muscular dystrophy trial results that triggered stock decline.
TRDAstock declinesecurities investigation